financetom
Business
financetom
/
Business
/
Newsletter | M-cap of BSE-listed companies crosses $4 Trillion mark; Charlie Munger dies at 99 & more
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newsletter | M-cap of BSE-listed companies crosses $4 Trillion mark; Charlie Munger dies at 99 & more
Nov 29, 2023 3:51 AM

Here's a rundown of 11 significant news stories to keep you in the know:

Share Market Live

NSE

#LatestNews⚡

Charlie Munger dies at 99: Here are 10 memorable quotes by the legend on investing and life

"The big money is not in the buying or selling, but in the waiting.” It implies that the most substantial gains in investing aren't typically made by frequently buying and selling stocks or assets in an attempt to time the market or capitalise on short-term fluctuations. Instead, significant wealth accumulation often comes from holding onto quality investments for extended periods, allowing time and the power of compounding to work in favour of the investor.

“A lot of people with high IQs are terrible investors because they’ve got terrible temperaments.”

This quote by Charlie Munger touches upon the notion that intelligence, as measured by IQ, doesn't necessarily correlate with success in investing.

Munger suggested that having a high IQ alone doesn't make someone a good investor. In fact, some exceptionally intelligent individuals may perform poorly in the world of investing due to their behavioral tendencies or temperament.

Market capitalisation of BSE-listed companies crosses $4 trillion mark

The overall market capitalisation of BSE-listed companies crossed the mark of $4 trillion on Wednesday, two-and-a-half years after crossing the $3 trillion mark.

Overall market capitalisation of BSE-listed companies had crossed $3 trillion for the first time on May 24, 2021.

Indian equities have had a stellar run over the last decade, with the Nifty 50 delivering positive annual returns for eight consecutive years. The index has gained 10% for 2023.

IREDA shares list at a 56% premium to IPO price, become second most successful PSU listing in 10 years

The shares of miniratna company Indian Renewable and Energy Development Agency Ltd (IREDA) debuted at a healthy premium of 56% on the exchanges in Wednesday's (November 29) trade. The stock listed at ₹50 on the NSE and the BSE over the IPO price of ₹32 apiece.

With this, the state-run company became the second most successful PSU listing in the last 10 years.

#TechTalks

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UTime to Implement 1-for-25 Reverse Stock Split
UTime to Implement 1-for-25 Reverse Stock Split
Sep 9, 2024
11:43 AM EDT, 09/09/2024 (MT Newswires) -- UTime ( WTO ) said Monday it is implementing a one-for-25 reverse stock split of its common stock starting Wednesday to comply with the Nasdaq's $1-per-share listing requirement. No fractional shares will be issued; instead, they will be rounded up to the nearest whole share, the company said. The company's shares were down...
ProStar Seeking $2 Million from a  Private Placement of Share Units
ProStar Seeking $2 Million from a Private Placement of Share Units
Sep 9, 2024
11:30 AM EDT, 09/09/2024 (MT Newswires) -- ProStar Holdings ( MAPPF ) on Monday said it is raising $2 million in a non-brokered private placement of share units to raise funds for sales, marketing and working capital. The offering consists of up to 12.5-million units priced at $0.16 each and made up of a share and a three-year warrant to...
Citi CFO expects investment banking fees to rise 20% in third quarter
Citi CFO expects investment banking fees to rise 20% in third quarter
Sep 9, 2024
NEW YORK (Reuters) -Citigroup's ( C/PN ) investment banking fees are expected to jump 20% in the third quarter from a year earlier, Chief Financial Officer Mark Mason told investors at a conference in New York on Monday. The gains are being driven by a good pickup in activity across debt capital markets and mergers and acquisitions, Mason said. Meanwhile,...
CorMedix Signs Contract for DefenCath Supply
CorMedix Signs Contract for DefenCath Supply
Sep 9, 2024
11:36 AM EDT, 09/09/2024 (MT Newswires) -- CorMedix ( CRMD ) said Monday it has signed a multiyear contract with an unnamed healthcare company to supply DefenCath to its facilities in the US. Shipments for DefenCath are expected to start in Q4, CorMedix ( CRMD ) said. DefenCath is indicated to reduce the incidence of catheter-related bloodstream infections in adult...
Copyright 2023-2024 - www.financetom.com All Rights Reserved